News

The Impact Journals news page hosts content about important news articles and press releases from our Journals and Editorial Board Members.

News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

Oncotarget | Treasures from trash in cancer research

News

November 23, 2022
PRESS RELEASE: On November 17, 2022, a new research perspective was published in Oncotarget, entitled, “Treasures from trash in cancer research.” continue reading »

Oncotarget | Association of fall rate and functional status by APOE genotype in cancer survivors after exercise intervention

News

November 21, 2022
PRESS RELEASE: A new research paper was published in Oncotarget on November 17, 2022, entitled, “Association of fall rate and functional status by APOE genotype in cancer survivors after exercise intervention.” continue reading »

Aging | The deubiquitylase USP7 is a novel cyclin F-interacting protein and regulates cyclin F protein stability

Aging

November 21, 2022
PRESS RELEASE: A new research paper was published in Aging's Volume 14, Issue 21, entitled, “The deubiquitylase USP7 is a novel cyclin F-interacting protein and regulates cyclin F protein stability.” continue reading »

Genes & Cancer | Expression of HOTAIR and MEG3 are negatively associated with H. pylori positive status in gastric cancer patients

Genes & Cancer

November 18, 2022
PRESS RELEASE: A new research paper was published in Genes & Cancer on February 10, 2022, entitled, “Expression of HOTAIR and MEG3 are negatively associated with H. pylori positive status in gastric cancer patients.” continue reading »

Oncotarget | Mutation analysis performed on tumor biopsies from patients with newly-diagnosed germinal center aggressive B cell lymphomas

News

November 17, 2022
PRESS RELEASE: On November 17, 2022, Oncotarget published a new research paper, entitled, “Mutation analysis performed on tumor biopsies from patients with newly-diagnosed germinal center aggressive B cell lymphomas.” continue reading »